The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지

Screening of ${\beta}$-Catenin/TCF Transcription Factor Inhibitors in Medicinal Herb Extracts

  • Choe, Ye-Dang (Department of Applied Chemistry, Dongduk Women's University Seoul) ;
  • Na, Byung-Jo (Weedam Korean Hospital Original Article) ;
  • Park, Se-Yeon (Department of Applied Chemistry, Dongduk Women's University Seoul)
  • Received : 2011.03.28
  • Accepted : 2011.05.11
  • Published : 2011.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This study was performed to screen target-specific inhibitors of ${\beta}$-catenin/TCF signaling whose functional activation plays an important role in early events in carcinogenesis. Methods: To investigate the activation or suppression of ${\beta}$-catenin/TCF transcription, we established a transiently transfected cell line with a constitutively active ${\beta}$-catenin mutant gene whose product is not degraded. This cell line was also co-transfected with luciferase reporter gene constructs containing either an optimized (TOPflash) or mutant (FOPflash) TCF-binding element. We investigated cytotoxic effects using a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt (MTS) assay. To find effective inhibitors of ${\beta}$-catenin/TCF signaling from medicinal herbs, the crude extracts of 99 types of medicinal herbs were screened using a luciferase assay system in HEK-293 and SH-SY5y cells. Results: At a concentration of $50{\mu}g$/ml, extracts of Angelica koreanae radix, Cannabis sativa semen, Ephedrae intermedia Schrenk radix, and Vitis rotundifolia fruit showed the following inhibitory effects on ${\beta}$-catenin/TCF signaling: $40{\pm}5.6%$, $23{\pm}6.1%$, $8{\pm}5.1%$, and $22{\pm}9.8%$ in ${\beta}$-catenin-activated HEK-293 cells and $9{\pm}4.7%$, $39{\pm}8.1%$, $39{\pm}6.4%$, and $42{\pm}10.1%$ in ${\beta}$-catenin-activated SH-SY5y cells, respectively. Crude extracts of E. radix were isolated by silica gel column chromatography, and two non-polar fractions of these extracts showed inhibitory effects on ${\beta}$-catenin/TCF signaling. Conclusions: In this study, we established a transiently transfected cell line as a screening system and found that various medicinal herb extracts had inhibitory effects on ${\beta}$signaling.

Keywords

References

  1. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999; 398(6726):422-6. https://doi.org/10.1038/18884
  2. Zhang F, White RL, Neufeld KL. Cell density and phosphorylation control the subcellular localization of adenomatous polyposis coli protein. Mol Cell Biol. 2001; 21(23):8143-56.
  3. Mareel M, Boterberg T, Noe V, Van Hoorde L, Vermeulen S, Bruyneel E, et al. E-cadherin/ catenin/cytoskeleton complex: a regulator of cancer invasion. J Cell Physiol. 1997; 173: 271-274. https://doi.org/10.1002/(SICI)1097-4652(199711)173:2<271::AID-JCP34>3.0.CO;2-G
  4. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S , Polakis P. Binding of GSK3b to the APC?${\beta}-catenin$ complex and regulation of complex assembly. Science. 1996; 272:1023-1026. https://doi.org/10.1126/science.272.5264.1023
  5. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. ${\beta}-catenin$ is a target for the ubiquitin proteasome pathway. EMBO J. 1997; 16:3797-3804. https://doi.org/10.1093/emboj/16.13.3797
  6. Luu HH, Zhang R, Haydon RC, Rayburn E, Kang Q, Si W, et al. Wnt/beta-catenin signaling pathway as a novel cancer drug target. Curr. Cancer Drug Targets. 2004; 4(8):653-71. https://doi.org/10.2174/1568009043332709
  7. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of ${\beta}-catenin$-TCF signaling in colon cancer by mutations in ${\beta}-catenin$ or APC. Science. 1997; 275:1787-1790. https://doi.org/10.1126/science.275.5307.1787
  8. Fujie H, Moriya K, Shintani Y, Tsutsumi T, Takayama T, Makuuchi M, et al. Frequent ${\beta}-catenin$ aberration in human hepatocellular carcinoma. Hepatol Res. 2001; 20:39-51. https://doi.org/10.1016/S1386-6346(00)00116-9
  9. Woo DK, Kim HS, Lee HS, Kang YH, Yang HK, Kim WH. Altered expression and mutation of ${\beta}-catenin$ gene in gastric carcinomas and cell lines. Int. J Cancer. 2001; 95:108-113. https://doi.org/10.1002/1097-0215(20010320)95:2<108::AID-IJC1019>3.0.CO;2-#
  10. Clements WM, Wang J, Sarnaik A, Kim OJ, MacDonald J, Fenoglio-Preiser C, et al. ${\beta}-catenin$ mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res. 2002; 62:3503-3506.
  11. Ho JW, Leung YK, Chan CP. Herbal medicine in the treatment of cancer. Curr. Med. Chem. Anticancer Agents. 2002; 2(2):209-14. https://doi.org/10.2174/1568011023354164
  12. Clapper ML, Coudry J, Chang WC. ${\beta}-catenin$-mediated signaling: a molecular target for early chemopreventive intervention. Mutat Res. 2004; 555:97-105.
  13. Dihlmann S, Siermann A, Doeberitz MK. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate bcatenin/TCF-4 signaling. Oncogene. 2001; 20:645-653. https://doi.org/10.1038/sj.onc.1204123
  14. Nath N, Kashfi K, Chen J, Rigas B. Nitric oxide-donating aspirin inhibits ${\beta}-catenin$/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear ${\beta}-catenin$-TCF association. Proc. Natl. Acad. Sci. U S A. 2003; 100:12584-12589. https://doi.org/10.1073/pnas.2134840100
  15. Zhou L, An N, Haydon RC, Zhou Q, Cheng H, Peng Y, et al. Tyrosine kinase inhibitor STI-57/ Gleevec down-regulates the ${\beta}-catenin$ signaling activity. Cancer Lett. 2003; 193:161-170. https://doi.org/10.1016/S0304-3835(03)00013-2
  16. Dashwood WM, Orner GA, Dashwood RH. Inhibition of ${\beta}-catenin$/TCF activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H2O2 at physiologically relevant EGCG concentrations, Biochem. Biophys. Res. Commun. 2002; 296:584-588. https://doi.org/10.1016/S0006-291X(02)00914-2
  17. Orner GA, Dashwood WM, Blum CA, Diaz GD, Li Q, Dashwood RH. Suppression of tumorigenesis in the Apcmin mouse: down-regulation of ${\beta}-catenin$ signaling by a combination of tea plus sulindac. Carcinogenesis. 2003; 24:263-267. https://doi.org/10.1093/carcin/24.2.263
  18. Dan B, Andrew G. 1992. Chinese Herbal Medicine. Materia Medica. Eastland Press: Seattle. 1992:32-34.
  19. Bielory L. Complementary and alternative interventions in asthma, allergy, and immunology. Annals of allergy, asthma & immunology 93. 2004:S45-S54. https://doi.org/10.1016/S1081-1206(10)61486-X
  20. Takara K, Horibe S, Obata Y, Yoshikawa E, Ohnishi N, Yokoyama T. Effects of 19 herbal extracts on the sensitivity to paclitaxel or 5-fluorouracil in HeLa cells. Biol Pharmaco Bull. 2005: 28:138-142. https://doi.org/10.1248/bpb.28.138